Concerns over efficacy, cost, and drug safety have stimulated a need for personalized medicine; and for improving the predictability of clinical and pre-clinical research to reduce development cost and time. The use of biomarkers is no longer restricted only to the identification of non-responder or responder population for therapeutic purposes. Biomarkers have now gained significant importance in the drug development process, and the market is thus perceived as an emerging but lucrative segment that is opening up new opportunities. It is therefore crucial to gain an understanding of the market dynamics, market size, and competitive landscape. However, most of the available reports do not provide a holistic analysis of biomarker market and neither do they focus on the micro-markets. This report’s exhaustive market segmentation captures relevant data pertaining to biomarker tools, services, and application markets, and thereby provides a complete picture of the biomarkers market.
Scope of the report
The report categorizes the global biomarker market as follows:
Tools Market (pre-genomic biomarkers and technologies, post-genomic biomarkers and technologies, imaging biomarkers, and others)
Services Market (pre- and post-clinical biomarker services, sample preparation, mirna analysis, and others)
Application Market (diagnosis, drug development and discovery)
What makes our reports unique?
We provide the longest market segmentation chain in the industry with our three-level market breakdown and our analysis of minimum 40 collectively exhaustive and mutually exclusive micro markets.
We provide 10% customization to ensure that our clients find the specific market intelligence they need.
Each report is about 150 pages, featuring 30+ market data tables, 30+ company profiles, and an analysis of 200 patents.
No single report by any other publisher provides market data for all market segments (i.e. products, services, applications, ingredients, and technology) covering the four geographies of North America, Europe, Asia Pacific, and ROW.
15 pages of high level analysis identifying opportunities, best practices, entry strategies, benchmarking strategies, market positioning, product positioning, and competitive positioning.
Key questions answered
Which are the high-growth segments and how is the market segmented in terms of applications, products, services, ingredients, technologies, stakeholders?
What are market estimates and forecasts; which markets are doing well and which are not?
Where are the gaps and opportunities; what factors are driving market growth?
Which are the key playing fields and winning-edge imperatives?
What is the competitive landscape; who are the main players in each segment; what are their strategic directives, operational strengths, key selling products, and product pipelines? Who is doing what?
Powerful Research and analysis
The analysts working with MarketsandMarkets come from renowned publishers and market research firms globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies.
Table of Content
1. market overview
1.1. Defining biomarker
1.2. Defining the biomarker market
1.3. Biomarker and its applications- Holistic view with respect to diagnosis and drug discovery
1.4. Cardiovascular and cancer diagnosis applications have high priority in the existing and future market scenario
1.5. Biomarker Pre and Post clinical services impacting the biomarker services market
1.6. biomarker patent analysis
2. summary
3. biomarker market dynamics
3.1. Drivers
3.1.1. high demand for biomarkers in drug discovery
3.1.2. BIOMARKERs help in the Early detection of drug failures
3.1.3. Biomarkers as cancer diagnostic tools
3.1.4. Cro RECOGNIZE VALUE OF biomarkerS IN drug development
3.1.5. Development in the life science fields such as proteomics and genomics enhances the biomarker applications
3.1.6. Support from FDA for biomarker development
3.2. Restraints
3.2.1. regulatory environment restrains the market growth
3.2.2. High initial investment hinders biomarker applicability
3.2.3. biomarker tests perceived to be unreliable
3.2.4. disapproval of diagnotic tools for biomarkers hinders the market growth
3.2.5. Biomarker validation approaches still not clearly addressed
3.2.6. Lack of web based solutions for biomarker discovery
figure 10 patent analysis by technology 2006 to 2008
figure 11 Patent analysis by competitors (2004-2008)
figure 12 patent analysis by geography
Figure 13 Biomarker clinical trial effectiveness
Figure 14 Biomarker applications in molecular diagnostics
Figure 15 imaging biomarkers APPLICATIONS in drug development
Figure 16 Common bioinformatics microarrays for biomarker discovery
Figure 17 Biomarker areas in drug development process
Figure 18 Global biomarker market by geography
Figure 19 Global biomarker tools market by geography
Figure 20 Global biomarker service market by geography
figure 21 geography wise biomarker market- global perspective
figure 22 Major segments focused by global biomarker players
Figure 23 Competitive landscape for strategy formation (2008-2009)
The Global Biomarker Market report analyzes the biomarker tools and services market over the period 2009-2014. The report studies the major market drivers, restraints, and opportunities for the global biomarker market; and also evaluates the major trends in the macro- and micro-markets with respect to different geographic regions.
Concerns over efficacy, cost and drug safety has ignited the personalized medicine need. There is a vast need of improving the predictability of clinical and pre-clinical research to reduce the development costs and time. Picking the right patient and supervising his progress has become a very common feature for the personalized therapies. The use of biomarker is not only restricted for the identification of non-responder or responder population for the therapeutics purpose but it also has a significant importance in the drug development process. The biomarker market in its growing stage is eyed as a lucrative segment that is opening up new opportunities. Hence understanding the market dynamics, market size and competitive landscape is crucial. However most of the reports that are available do not provide a holistic aspect of biomarker market and do not focus on the micro markets. The market segmentation of this report is exhaustive and captures relevant data pertaining to biomarker tools, services and application markets and thereby providing a complete picture of the biomarkers market.
The global biomarker market is estimated to be $20.5 billion by 2014, growing at a CAGR of 19.7 % from 2009 to 2014, driven by the high demand for the biomarkers in the field of drug discovery. The markets for biomarker tools and services are expected to grow at a CAGR of 18.5% and 22.2% respectively. The increasing use of biomarkers in clinical services is boosting the overall biomarker service market. The illustration shows the applications of biomarker in various fields such as cancer. Biomarkers are being intensively applied in the drug discovery and diagnostic applications with the rising demand for technologies for early clinical development phase.
Biomarker Applications
The high growth of biomarker market is boosted by the demand from the baby boomer generation in the U.S., and from Asia’s emerging IT industry. Biomarker applications are increasing in cancer diagnosis as novel tools are being developed to increase the discovery speed of cancer biomarkers. The use of proteomics in biomarker testing and identification has in turn boosted the services for the biomarkers. Market players are now focusing on new product and service development to enhance their commercial portfolios. Strategic collaborations among companies are also increasing biomarker applications in the field of diagnosis and drug discovery.
Please fill in the form below to receive a sample copy of the report.
Custom Research
We will customize the research for you, in case the report listed above does not
meet with your exact requirements. Our custom research will comprehensively cover
the business information you require to help you arrive at strategic and profitable
business decisions.
